AlphaMadera's AlphaVal page computes PG&E Corporation's fair value using a multi-method blend (DCF, comparable-multiples, and Graham-style intrinsic value), then compares it to the current market price to flag PCG as undervalued, fairly valued, or overvalued.

What is PG&E Corporation's fair value?

Fair value for PCG is a model output combining discounted cash flow projections, peer-group multiples, and a Graham number floor. The live AlphaVal page shows the blended fair value alongside each method's individual estimate.

How does AlphaMadera value PCG?

AlphaVal uses three primary techniques: a five-year discounted-cash-flow projection with terminal multiple, peer-group multiple analysis (P/E, EV/EBITDA, P/S), and Graham's defensive-investor intrinsic-value formula. Inputs come from PCG's most recent reported fundamentals.

PCG - PG&E Corporation

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $22.67 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 85% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Undervalued Moderate

Trading 30.2% below fair value

Current Price $17.18

Bear Case $21.53 25.3% upside ($21.53 - $17.18) / $17.18 = 25.3% $1.59 × 14x P/E

Fair Value $24.61 43.2% upside ($24.61 - $17.18) / $17.18 = 43.2% $1.59 × 16x P/E

Bull Case $27.69 61.1% upside ($27.69 - $17.18) / $17.18 = 61.1% $1.59 × 18x P/E

Adjust Assumptions

P/E Multiple

16.0x

Adjusted EPS

1.59$

Key Value Driver

Normalized P/E multiple (16x base case)

Implied Market Multiple 10.8x

Plain-Language Summary

Our base-case estimate uses a valuation based on adjusted earnings per share and a normalized price-to-earnings multiple. We then blend that result with the average analyst price target of $22.67 from 30 analysts, using a 30% weight on analyst consensus. That produces an estimated intrinsic value of $24.61 per share.

Warnings

⚠ The company's reported profits differ from official accounting profits by 35%. Check what costs are being left out of the adjusted number.

Key Risks

Growth DCF inappropriate — terminal value assumptions dominate
EV/EBITDA misleading for regulated businesses where capex is mandated
Regulatory risk is a fat tail not visible in normal multiples